Marketing-authorisation holder
Sagent Pharmaceuticals, Inc
17 medicines in 2 countries, as authorisation holder and manufacturer.
Medicines
Every medicine in the registers under its name, current ones first.
17 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CALCITRIOL0.001mg/ml | 0.002mg/ml · Injectable | Calcitriol | United States | Marketed | 2002 |
| DIHYDROERGOTAMINE MESYLATE1mg/ml · Injectable | Dihydroergotamine | United States | Marketed | 2003 |
| DOXORUBICIN HYDROCHLORIDE10mg/vial | 150mg/75ml | 150mg/vial | 200mg/100ml | 20mg/vial | 2mg/ml | 50mg/vial · Injectable | Doxorubicin | United States | Marketed | 1974 |
| FAMOTIDINE10mg/ml · Injectable | Famotidine | United States | Marketed | 1998 |
| FAMOTIDINE200mg/50ml (4mg/ml) | 20mg/5ml (4mg/ml) | 40mg/10ml (4mg/ml) · Solution | Famotidine | United States | Marketed | 2025 |
| GLYDO2% · Jelly | Lidocaine | United States | Marketed | 2014 |
| HALOPERIDOL5MG in 10ML VIALS · Injectable | Haloperidol | United States | Marketed | |
| METHOCARBAMOL1gm/10ml (100mg/ml) · Solution | Methocarbamol | United States | Marketed | 2014 |
| NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE16mg base/250ml (eq 64mcg base/ml) | 4mg base/250ml (eq 16mcg base/ml) | 8mg base/250ml (eq 32mcg base/ml) · Solution | Norepinephrine | United States | Marketed | 2021 |
| OCTREOTIDE ACETATE (PRESERVATIVE FREE)0.05mg base/ml | 0.1mg base/ml | 0.5mg base/ml · Injectable | Octreotide | United States | Marketed | 2005 |
| OXACILLIN SODIUM10GM BASE/VIAL | 125MG BASE/VIAL | 1GM BASE/VIAL | 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 250MG BASE/VIAL | 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2GM BASE/VIAL | 2GM BASE/VIAL **Federal Register determinatio · Injectable | Oxacilina | United States | Marketed | 1971 |
| OXYTOCIN100usp units/10ml (10usp units/ml) | 10usp units/ml (10usp units/ml) | 300usp units/30ml (10usp units/ml) · Injectable | Oxytocin | United States | Marketed | 1980 |
| PENTOBARBITAL SODIUM50mg/ml · Injectable | Pentobarbital | United States | Marketed | 1973 |
| TOPOTECAN HYDROCHLORIDE4mg base/vial · Injectable | Topotecan | United States | Marketed | 2010 |
| VALPROATE SODIUM100mg base/ml · Injectable | Valproic acid | United States | Marketed | 2002 |
| Ezokamine | Micafungin | Saudi Arabia | Authorised | |
| FOSAPREPITANT DIMEGLUMINEUnknown | Fosaprepitant dimeglumine unknown | United States | tentative | 2017 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 16 | 15 | 1 | CompaniesAll medicines |
| Saudi Arabia | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- sagent
- sagent pharmaceuticals inc
- sagent pharms
- sagent pharms inc
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 17
- Countries
- 2
- Roles
- Authorisation holder and manufacturer